[{"address1": "3805 Old Easton Road", "city": "Doylestown", "state": "PA", "zip": "18902", "country": "United States", "phone": "(215) 948-4119", "website": "https://aprea.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidates are APR-1051, an orally bioavailable small-molecule inhibitor of WEE1 kinase that is in Phase 1 clinical trial for the treatment of patients with advanced solid tumors with biomarkers; and ATRN-119, an ATR inhibitor, which is in Phase 1/2a clinical trial for solid tumor indications. The company is headquartered in Doylestown, Pennsylvania.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Dr. Oren  Gilad Ph.D.", "age": 56, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 575490, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John P. Hamill CPA", "age": 60, "title": "Senior VP, CFO, Principal Accounting Officer & Secretary", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 444280, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lars B. Abrahmsen Ph.D.", "age": 67, "title": "Senior VP & Chief Scientific Officer", "yearBorn": 1957, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian  Wiley", "age": 56, "title": "Senior Vice President of Corporate Development & Strategy", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michel  Afargan Ph.D.", "title": "Head of Pharmacology Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ze'ev  Weiss B.Sc., C.P.A.", "age": 62, "title": "Chief Business Advisor", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Andrea  Epstein", "title": "Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.575, "open": 1.65, "dayLow": 1.56, "dayHigh": 1.7, "regularMarketPreviousClose": 1.575, "regularMarketOpen": 1.65, "regularMarketDayLow": 1.56, "regularMarketDayHigh": 1.7, "payoutRatio": 0.0, "beta": 1.585, "forwardPE": -1.6127452, "volume": 41412, "regularMarketVolume": 41412, "averageVolume": 50962, "averageVolume10days": 27770, "averageDailyVolume10Day": 27770, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 9582553, "fiftyTwoWeekLow": 1.412, "fiftyTwoWeekHigh": 5.01, "priceToSalesTrailing12Months": 11.394074, "fiftyDayAverage": 1.73206, "twoHundredDayAverage": 2.455535, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -6222283, "profitMargins": 0.0, "floatShares": 4635801, "sharesOutstanding": 5825260, "sharesShort": 56425, "sharesShortPriorMonth": 79127, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.010199999, "heldPercentInsiders": 0.11304, "heldPercentInstitutions": 0.31190002, "shortRatio": 1.18, "shortPercentOfFloat": 0.0116, "impliedSharesOutstanding": 5825260, "bookValue": 2.332, "priceToBook": 0.7054031, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -13850097, "trailingEps": -2.3, "forwardEps": -1.02, "lastSplitFactor": "1:20", "lastSplitDate": 1676246400, "enterpriseToRevenue": -7.399, "enterpriseToEbitda": 0.421, "52WeekChange": -0.5366197, "SandP52WeekChange": 0.1513431, "quoteType": "EQUITY", "currentPrice": 1.645, "targetHighPrice": 11.0, "targetLowPrice": 10.0, "targetMeanPrice": 10.5, "targetMedianPrice": 10.5, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 2, "totalCash": 16532199, "totalCashPerShare": 2.838, "ebitda": -14774702, "totalDebt": 0, "quickRatio": 5.219, "currentRatio": 5.344, "totalRevenue": 841012, "revenuePerShare": 0.14, "returnOnAssets": -0.39124, "returnOnEquity": -0.67541003, "grossProfits": -8759752, "freeCashflow": -8152045, "operatingCashflow": -12741123, "revenueGrowth": -0.79, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -28.682959, "financialCurrency": "USD", "symbol": "APRE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1755901801, "regularMarketTime": 1755892800, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1570109400000, "postMarketChangePercent": -2.73556, "postMarketPrice": 1.6, "postMarketChange": -0.045, "regularMarketChange": 0.06999993, "regularMarketDayRange": "1.56 - 1.7", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 50962, "fiftyTwoWeekLowChange": 0.23300004, "fiftyTwoWeekLowChangePercent": 0.16501419, "fiftyTwoWeekRange": "1.412 - 5.01", "fiftyTwoWeekHighChange": -3.3650002, "fiftyTwoWeekHighChangePercent": -0.6716567, "fiftyTwoWeekChangePercent": -53.661972, "earningsTimestampStart": 1754915400, "earningsTimestampEnd": 1755261000, "isEarningsDateEstimate": true, "marketState": "CLOSED", "exchange": "NCM", "messageBoardId": "finmb_329831339", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Aprea Therapeutics, Inc.", "longName": "Aprea Therapeutics, Inc.", "epsTrailingTwelveMonths": -2.3, "epsForward": -1.02, "epsCurrentYear": -0.67, "priceEpsCurrentYear": -2.4552238, "fiftyDayAverageChange": -0.087059975, "fiftyDayAverageChangePercent": -0.050263833, "twoHundredDayAverageChange": -0.81053495, "twoHundredDayAverageChangePercent": -0.3300849, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "regularMarketChangePercent": 4.44444, "regularMarketPrice": 1.645, "displayName": "Aprea Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-08-23"}]